The CMO Market Outlook to 2017

Report Summary

This report examines the markets for contract manufacturing of finished dose forms and clinical quantity pharmaceuticals. The report forecasts CMO markets for the US, Western Europe, Eastern Europe, China, India, Other Asia, Latin America and the rest of the world to 2017. Drivers and restraints for each regional market as well as the global market are also examined.

Features and benefits

• Develop contract manufacturing strategies based on regional forecast performance and key industry trends.
• Analyze the strengths and weaknesses of global players in the CMO market.
• Evaluate the future outlook of clinical quantity manufacturing as against finished dose supply.
• Assess the effects of CROs and big pharma drugmakers on the CMO market.
• Forecast CMO market sizes by region to 2017.

Highlights

In 2011, total global spending on outsourced drug manufacturing reached $31.9bn, having expanded at a double-digit pace over the past two decades. Over the next five years, the CMO industry will continue to record strong gains, with total revenues rising by 12.0% per year, on average.

In 2011, the US and Western Europe accounted for a combined $23.3bn in CMO revenues from services performed in these regions, representing 73% of total global CMO fees of $31.9bn. However, China, India, Eastern Europe, Latin America, and Other Asia regions will outpace the traditional manufacturing centres of the US and Western Europe.

In 2012 and 2013, drug manufacturers will be extremely cautious about investments in new technologies, equipment or facilities, preferring to outsource to established experts rather than incur heavy capital costs of building, expanding or upgrading their own internal capabilities, which will stimulate contract manufacturing.

Your key questions answered

• What factors are underpinning continued growth of the CMO market?
• Which regions will experience the greatest growth of CMO activity and how can sponsors optimize their work with CMOs in these areas?
• Between China and India, which has the greater potential for contract manufacturing to 2017?
• What are the leading players in each global region, and what are their recent activities?
• What is the potential of the Latin American and Eastern European CMO markets?

Table of Contents

About the author
Disclaimer

EXECUTIVE SUMMARY
The shifting drug manufacturing landscape
The continued growth of contract manufacturing
Continued demand in the established regions
Strong growth in the emerging regions
Leading global CMOs
The future of contract manufacturing
The shifting drug manufacturing landscape
Summary
Introduction
Rising pressures on drug makers
Blockbuster patent expirations and genericization
Decreasing drug approvals
Drug pricing pressures
Excess manufacturing capacity
Technology shifts
Biotechnology
Conclusion
The continued growth of contract manufacturing
Summary
Contract manufacturing organizations
The role of CMOs
Services offered by CMOs
CMO usage, 2012–2017
Global CMO forecasts by segment
Global CMO forecasts by world region
Drivers of rising CMO usage
Cost savings
Risk reduction
Shifting manufacturing requirements
Lead time savings
Access to expertise
Expansion of overseas CMOs
Entrance of Big Pharma into contract manufacturing
Vertical integration with CROs
Emergence of specialty CMO players
Risk sharing programs
Restraints inhibiting greater CMO usage
Pharma industry consolidation
Lack of specialized manufacturing capacity
Manufacturing budget reductions
Heightened regulatory scrutiny
CMO personnel shortages
CMO alternatives
Conclusion
Continued demand in the established regions
Summary
Introduction
The US CMO market
Overview
US CMO usage by segment, 2011–2017
The Western European CRO market
Overview
Western European CMO usage by segment, 2011–2017
Conclusion
Strong growth in the emerging regions
Summary
Introduction
The Eastern European CMO market
Overview
The Chinese CMO market
Overview
Chinese CMO usage by segment, 2011–2017
The Indian CMO market
Overview
Indian CMO usage by segment, 2011–2017
The Asian CMO market, exclusive of China and India
Overview
Other Asian CMO usage by segment, 2011–2017
The Latin American CRO market
Overview
Latin American CMO usage by segment, 2011–2017
ConclusionThe emerging global markets for pharmaceutical contract manufacturing are growing quickly, fueled by sponsors’ desire to reduce costs while improving manufacturing efficiencies. Each region, however, is subject to varying drivers and restraints based upon its own economy, demographics, legal and regulatory system/s, infrastructure, patent laws and other issues. While India and China are known for their high growth, other regions including Eastern Europe, Other Asian countries and Latin America also offer significant opportunities for both sponsors and third party organizations.
Leading global CMOs
Summary
Introduction
Leading Players
Aenova
Boehringer Ingelheim
Catalent Pharma Solutions
Dr. Reddy’s
DSM
Fareva
Haupt
Jubilant Organosys
Lonza
Patheon
Piramal
Tianjin Pharmaceutical
Conclusion
The future of contract manufacturing
Summary
Introduction
The drug manufacturing landscape in the US and EU
Near term: 2012–2013
Long term: 2014–2017
Manufacturing outsourcing trends
Near term: 2012–2013
Long term: 2014–2017
Conclusion

Appendix
Scope
Methodology
Primary research
Secondary research
Glossary/Abbreviations
Bibliography/References

List of Figures

Figure: Usage of clinical and final dosage CMO services by type of drug maker
Figure: Global CMO market by segment ($bn), 2012–17
Figure: CMO market by region ($bn)
Figure: CMO fees in the established regions ($bn), 2011–17
Figure: US CMO fees by segment ($bn), 2011–17
Figure: US CMO market players by market share, 2011
Figure: Western European CMO fees by segment ($bn), 2011–17
Figure: Western European CMO market players by market share, 2011
Figure: Eastern European CMO fees by segment ($bn), 2011–17
Figure: Eastern European CMO market players by market share, 2011
Figure: Chinese CMO fees by segment ($bn), 2011–17
Figure: Chinese CMO market players by market share, 2011
Figure: Indian CMO fees by segment ($bn), 2011–17
Figure: Indian CMO market players by market share, 2011
Figure: Other Asian CMO fees by segment ($bn), 2011–17
Figure: Leading Other Asian CMO market players, 2011
Figure: Latin American CMO fees by segment ($bn), 2011–17
Figure: Leading Latin American CMO market players, 2011
Figure: Forces driving and restraining CMO growth in the near and long term